Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net product revenues	$ 1,274	$ 0	$ 2,139	$ 0
Cost of product sales	351	0	551	0
Gross margin	923	0	1,588	0
Operating expenses:
Research and development	2,046	4,749	3,747	8,979
Selling, general and administrative	21,860	3,588	49,871	6,661
Total operating expenses	23,906	8,337	53,618	15,640
Loss from operations	(22,983)	(8,337)	(52,030)	(15,640)
Other (income) expense:
Interest income	(582)	(60)	(1,058)	(95)
Interest expense	2,301	0	4,494	862
Foreign currency (gains) losses	24	(25)	21	(31)
Net loss	(24,581)	(8,208)	(55,154)	(16,283)
Deemed dividend	0	4,083	0	7,150
Accretion to redemption value	0	546	0	1,074
Net loss attributable to common stockholders	$ (24,581)	$ (12,837)	$ (55,154)	$ (24,507)
Net loss per share of common stock
basic (in USD per share)	$ (0.64)	$ (3.16)	$ (1.44)	$ (6.02)
diluted (in USD per share)	$ (0.64)	$ (3.16)	$ (1.44)	$ (6.02)
Weighted average common shares outstanding
basic (in shares)	38,688,366	4,067,717	38,271,101	4,067,717
diluted (in shares)	38,688,366	4,067,717	38,271,101	4,067,717
Grant and other income
Other (income) expense:
Grant and other income	$ (145)	$ (44)	$ (333)	$ (93)